Assessment of the impact of Orphan Medicinal Products (OMPs) on the European Economy and Society


Report from the first BIO-EuropaBio Workshop on Health Technology Assessments and Comparative Effectiveness, which took place in Brussels on 13 November 2008. 

The purpose of this first workshop was to examine the academic underpinnings of HTA, consider the HTA models of a number of countries, and share experiences of the impact of the different ways in which HTA is being interpreted and applied.